Fuda Cancer Hospital - Philippines

Home
Philippines
Makati
Fuda Cancer Hospital - Philippines

Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 10,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries.

30/12/2025

DEC.30.2025.
.
[Patient Stories] [Kenyan – Pancreatic Cancer – Nanoknife]
>>> Two Miracles：Kenyan Woman Finds Hope Under the Shadow of the “King of Cancers” > https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

20/12/2025

Dec.20.2025.
.
[Patient Story] [Kenya · Pancreatic Cancer · NanoKnife]
Two Miracles: A Kenyan Woman Finds a Bloom of Hope Under the Shadow of the “King of Cancers”
A year ago, she was tormented by advanced pancreatic cancer and advised by local doctors to “go home.” Today, she is living independently, full of energy and spirit. This extension of life represents the dedication and perseverance of countless healthcare professionals—and bears witness to the remarkable outcomes that can be achieved when advanced medical technology meets genuine human care.
From Helicobacter pylori to a “Mass”
Maureen (pseudonym), from Kenya, began experiencing abdominal discomfort in February last year. Local doctors initially suspected a Helicobacter pylori infection. However, after a period of anti-infective treatment, her pain did not improve. Sensing something was wrong, she underwent further examinations, and an ultrasound revealed a mass in the pancreas.
As a healthcare professional herself—and a breast cancer survivor—Maureen was acutely sensitive to the word “mass.” She immediately traveled to India for hospitalization. After a series of tests, she was confronted with a suffocating diagnosis: pancreatic adenocarcinoma, often referred to as the “king of cancers.”
576CD4A6-5CB1-4012-B277-7F7A9F80A9BC.png
Due to the tumor’s unfavorable location and large size, surgeons told her that open surgery was not an option. She was offered two alternatives: NanoKnife ablation or chemotherapy. At the time, Maureen had never even heard of NanoKnife. When she learned that the procedure could take up to eight hours, she firmly refused. “Limited experience, immature technique, long duration, and high risk”—that was her assessment then. Physically weak, she did not dare to undergo such a lengthy procedure and chose chemotherapy instead.
However, after four cycles of chemotherapy, the treatment showed minimal effect while the side effects were devastating. Seeking another evaluation from a gastrointestinal specialist, she was told, “This cancer may not be sensitive to chemotherapy.” She then underwent five sessions of stereotactic body radiotherapy (SBRT), but the tumor still failed to shrink. Her pain worsened, analgesics gradually lost effect, and her weight dropped from 70 kg to 54 kg.
“Doctors advised me to go home.”
Those words felt like a final verdict. Even Maureen, who had never wanted to give up, found herself on the brink of despair.
A Lifeline Across the Ocean
Hope emerged from the depths of desperation. Her nephew, who works in medical tourism, learned of her situation and quickly contacted the India office of Fuda Cancer Hospital, Guangzhou. After a comprehensive evaluation, the medical team proposed a new treatment strategy: a combination of NanoKnife ablation, interventional therapy, and immunotherapy.
After learning about Fuda’s extensive experience with NanoKnife technology, Maureen embarked on her journey to China in June this year. By then, her condition was extremely poor: no appetite, little will to live, and in her own words, “I didn’t even look like a human being anymore.”
Arriving late at night at the Fourth Medical Department of Fuda Cancer Hospital, the unfamiliar surroundings, jet lag, and relentless pain left her physically and emotionally exhausted. Yet a small, thoughtful gesture by the nursing staff—preparing a meal for her—instantly warmed her heart in a foreign land.
483FBB58-1121-4AB0-B783-C663226E123E.png
Examinations revealed that her pancreatic cancer was already at Stage III, with secondary malignant retroperitoneal lymph node involvement, making curative surgery impossible. Dr. Pang Xiaoming explained her condition clearly in plain language, patiently listening to her needs to tailor a more suitable treatment plan.
DB72A462-43ED-47EC-A1D3-D5F4F13C9052.png
After multidisciplinary consultation, the team performed NanoKnife ablation of the pancreatic tumor combined with celiac plexus neurolysis. Postoperatively, immunotherapy was administered to control the tumor while alleviating cancer-related pain.
8BEADFF9-37AC-404A-BD7B-09000591528A.png
E35EE7E6-EEF7-4F00-8D7B-41DEA4560A65.jpg
9076B0D9-31D7-4CC9-85BB-57D6455E4BC7.jpg
DCBBD576-6AE1-4D64-B89F-7AC93E083175.jpg
BFD0FCE0-7EE3-45E3-A58D-AD10275285BC.jpg
“NanoKnife ablation took less than an hour,” Maureen recalled—starkly different from the eight hours she had once feared. Even during her night of observation in the ICU, the warm companionship of the medical staff gave her a profound sense of security. In the days following surgery, miracles began to unfold: her appetite returned, she could sleep through the night, and her weight gradually increased. She later underwent arterial infusion chemotherapy.
C54CBD26-3CA0-402B-B8D3-C83E026BF194.png
“After returning home, I visited my original gastrointestinal doctor. He was shocked and said I must have received very high-quality treatment to have ‘come back to life,’” she said. Although the tumor had not shrunk dramatically and some marginal activity remained, most of the lesion was necrotic. More importantly, her strength, energy, and quality of life were all steadily improving. In the face of the “king of cancers,” Maureen had won a hard-fought battle.
80F1DE9A-08E1-49D3-82BD-5067AA3BC449.png
A Dual Victory of Technology and Humanity
Maureen describes her journey with two “miracles”:
The first miracle was the exceptional medical expertise and humanistic care of the Fuda team—not only the efficiency of NanoKnife technology, but also the doctors’ and nurses’ willingness to listen and communicate with genuine empathy.
The second miracle was the comprehensive improvement of her body after treatment—a life-saving outcome created through the joint efforts of both doctors and patient.
Here, she felt true empathy from the medical staff, mutual support from fellow patients, and meticulous hospital services—from interpretation and transportation to thoughtful facilities such as a shared kitchen. All of this made her feel that she was “not trapped in a cage,” but instead empowered to fight cancer.
363DB8CD-6CB0-4DD5-83CF-71971DED8839.png
Her mindset transformed from resignation to openness. She hopes her experience can encourage other cancer patients:
“Don’t be afraid. There is always a method that suits you. Even in the darkest moments, never give up searching for the possibility of light.”

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

12/12/2025

DEC.12.2025.
.
[Minimally invasive treatment] [Robotic Navigation System-Lung Nodule]
>>>Percutaneous Lung Nodule Ablation with a Robotic Navigation System> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 916 775 3426.
🌍 Website: https://en.fudahospital.com/

10/12/2025

DEC.10.2025.
.
[Patient Story | Malaysia – Lung Cancer – Interventional Therapy]
>>> From Wheelchair to Walking Again: He Recovered from Metastatic Lung Cancer in Just Three Months > https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

06/12/2025

DEC.5.2025.
.
[Minimally invasive treatment] [Brunei-Pancreatic Cancer-Nanoknife]
>>>Seize the "Pancreatic" Vitality: Nanoknife Precisely Destroys Tumors> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

01/12/2025

FUDA CANCER HOSPITAL ANNOUNCEMENT UPDATE: DECEMBER.2025.
Good day.
Greetings from Fuda Ph Consultation Office.
Dr. Phoong from Fuda China will provide second opinion consultation on option to treat early and advanced stages Cancer. For interested New and Old Patient pls kindly send your RSVP.

DEC.12- FRI (MAKATI).
9am-12nn.(FACE TO FACE).
2pm-5pm. (VIDEO CONSULTATION).

DEC.13 - SAT (MAKATI).
9am-12nn. (FACE TO FACE).

Thank you.
RSVP: (VIBER & WHATSAPP).
Mr. Cruz, SEGUNDO III
+63 917 775 3426
Ms. Catenza, MARINETTE
+63 917 861 3426
Ms. De Leon, MARY JANE
+63 947 457 6904

MAKATI OFFICE ADDRESS:
Unit 2522, 25th floor, CENTURIA MEDICAL MAKATI BUILDING, Kalayaan Avenue corner Salamanca St. Brgy. Poblacion Makati City 1210.
FYI: Guest Parking is located at B3-B5.

DAVAO CITY: (VIDEO CONSULTATION)
SUREHEALTH 360
10th Floor Lanang Premiere Doctors Hospital Inc. Davao Park District (Dacudao Loop). 8000 Davao City Philippines.

25/11/2025

NOV.25.2025.
.
[Fuda News] [International Conference – NanoKnife]
China’s Voice on the Global Stage: President Niu Lizhi Shares NanoKnife Achievements, Sparking Active Q&A
At the recent ANGIODYNAMICS INTERNATIONAL LIFE SYMPOSIUM, Dr. Niu Lizhi, President of Guangzhou Fuda Cancer Hospital, traveled to Europe to present to leading experts worldwide the current status of NanoKnife ablation technology in China, as well as China’s clinical experience and outcomes using NanoKnife combined with chemotherapy in treating hilar cholangiocarcinoma. This breakthrough therapy drew strong interest from international participants, prompting an enthusiastic Q&A session.
29126BE6-6571-470D-B489-FCFD2E29D657.jpg
Hilar cholangiocarcinoma is notoriously difficult to treat due to its complex anatomical location. Tumors often invade major vascular structures, and most patients lose the opportunity for curative surgery by the time of diagnosis. For those with advanced, unresectable disease, traditional treatment options remain limited, and a breakthrough therapy is urgently needed. NanoKnife ablation has emerged as one such breakthrough in addressing this global clinical challenge.
3B9584E4-108F-4B69-9BF9-C7BB7A3557BB.jpg
A3995E91-8079-4F37-B861-B02662566409.jpg
The NanoKnife, also known as Irreversible Electroporation (IRE), is a non-thermal tumor ablation technique. It delivers microsecond high-voltage electrical pulses that create nanoscale pores in cancer cell membranes, inducing apoptosis while preserving nearby vital structures such as blood vessels, nerves, and bile ducts. This makes it particularly suitable for tumors located in anatomically complex regions such as the hepatic hilum, gallbladder and bile ducts, and pancreas.
As one of the earliest hospitals in China to adopt NanoKnife technology, Guangzhou Fuda Cancer Hospital has successfully performed thousands of NanoKnife ablation procedures, ranking among the world’s leading centers. The hospital has also developed a comprehensive treatment system and clinical pathway, enabling the Chinese team to accumulate extensive experience and offer new hope to patients with unresectable hilar cholangiocarcinoma. During the conference, Dr. Niupresented clinical data demonstrating outcomes significantly superior to traditional monotherapies, attracting wide attention from attendees.
146EF03F-20D8-4701-ACC9-CC5D4D0AA2E6.jpg 2A573626-23E5-422E-9566-713F9C5A7E9C.jpg
NanoKnife is not a stand-alone treatment but a key component of a multidisciplinary approach. The integration of local ablation and systemic therapy is expected to become an important trend in the future management of hilar cholangiocarcinoma. With continuous advancements in China’s medical technology and deepening international collaboration, more innovative Chinese treatment approaches are stepping onto the global stage. Guangzhou FudaCancer Hospital will continue to contribute China’s wisdom and strength to the worldwide fight against cancer.

Click to read more patient stories

https://en.fudahospital.com/
📞 Contact us via:
Phone: +63 917 775 3426.
WhatsApp: +63 917 775 3426.
Website: https://en.fudahospital.com

21/11/2025

NOV.21.2025.
.
[Patient Stories] [China – Breast cancer liver metastasis – Interventional chemo]
>>> Surviving Liver Metastasis: Breast Cancer Patient’s Fight Back > https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

19/11/2025

NOV.19.2025.
.
[Breaking News] [Indonesia – Sudden Carotid Artery Rupture Caused by Right Cervical Spindle Cell Sarcoma]
1,000 ml of Blood Loss, Three Life-Saving Relays, and an 18-Hour Extreme Rescue
At 11 p.m., the lights at Guangzhou Fuda Cancer Hospital were still blazing. A desperate race against death was unfolding—an Indonesian patient suffered a sudden massive hemorrhage after a spindle cell sarcoma in the right neck invaded the carotid artery and ruptured. In an instant, blood spurted out violently. The patient lost nearly 1,000 ml of blood.
A silent life alarm was triggered. In the critical moment, Dr. Jia Xintong and the on-duty nurses became the first line of defense. Without hesitation, they rushed forward and pressed firmly on the bleeding site with their bare hands.That single press lasted one full hour. Every second was a countdown to life; every second was held up by unwavering determination and a sense of sacred duty.
2323F5AE-327B-47FC-8DA9-671CBD964A15.png
Life-saving efforts could not wait. Relevant departments mobilized instantly and cooperated with precision. Interventional specialist Director Yang Qingfeng and Dr. Qiu Ningning rushed to the hospital from home in the middle of the night to begin the first lifesaving relay—performing emergency embolization to stop the bleeding. In the stillness of the early morning, their expertise and persistence guarded the first glimmer of hope.
The lights in the blood bank also stayed on through the night. Thanks to the blood reserves from the hospital’s fourth voluntary staff donation drive this year, the clinical supply remained secure.
When a specific blood type ran critically low, a driver from the service department volunteered immediately:
“I know the route well. I’ll take it!”
Gripping the steering wheel, he raced through the dark city to deliver the urgently needed blood to the operating floor at top speed. This invisible lifeline was reinforced by every ordinary person making extraordinary efforts.
1DC3207B-CFE2-4CA9-A9BB-D13F5B0EDC45.jpg 687D8DA6-935A-43CD-9B83-A30E372CA7B5.jpg
Meanwhile, Dr. Liu Zhengping and the team in Indonesia stayed awake with their phones in hand, anxiously following the situation in Guangzhou. Cross-border updates, translated in real time, connected the care and expertise of both countries.
After an urgent multidisciplinary evaluation led by President Niu Lizhi, Prof. Zeng Zongyuan, Director Xu Jiongyuan, and external experts, the team decided to implant a covered stent. Like tightly interlocking gears, all departments activated emergency protocols with flawless coordination, opening a seamless green channel for the patient.

Yet at the moment hope appeared, a slight jolt during bed transfer triggered another catastrophic hemorrhage. In the split second between life and death, Dr. Wang Jie Fu pressed down on the wound with the grip of an iron clamp.
In a storm of gushing blood, he remained motionless—a human hemostatic forceps—buying the surgical team invaluable time. After more than three hours of continuous manual compression, the surgery succeeded, and the covered stent was finally implanted.
2A24F454-0808-48A5-ACC6-78D0934946FC.jpg 101E0CE7-2FAF-40D5-9DCC-651212CB7B35.jpg
An 18-Hour Battle Across Two Countries
When the life-threatening crisis was finally resolved, hearts across Guangzhou and Indonesia could at last relax. Behind this 18-hour rescue was the seamless coordination of the Interventional Department, ICU, Anesthesia Department, Procurement, and the translation team—an inspiring portrait of cross-department unity and courage.
And this was not an isolated case. Just last month, the same team carried out another nerve-wracking rescue: An Indonesian patient with an oral tumor suffered sudden massive bleeding, and all conventional hemostatic measures failed. In the moment of crisis, Dr. Wang Jie Fu once again stepped forward, manually pressing the bleeding point for more than two hours, creating a critical window for the interventional and anesthesia teams. After 45 minutes of coordinated effort, they successfully embolized the vessel and claimed another victory.
E96FEEEE-2B84-40A1-940D-527DD0BC488F.png
On This Battlefield Without Smoke and beneath the white coats lie not only superb medical skills,but shields of flesh and blood that protect life.Not only duty, but compassion—the resolve to guard life with life.

Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

15/11/2025

NOV.15.2025.
.
[Patient Stories] [Sharing is Caring][Malaysia – Liver nodules – Interventional Chemo]
>>> EP1: Companionship means a lot > https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Address

Unit 2522, 25th Floor, Centuria Medical Makati Building
Makati
1210

Telephone

+639177753426

Website

http://phl.fudahospital.com/

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Philippines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Makati?

Our Story

Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 12,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries. Fuda is also a Joint Commission International (JCI) accredited, JCI is from the USA that monitors all private and government hospitals in the world to follow the international standard patient and treatment safety protocols. Fuda Makati Satellite office offers second opinion consultation to review and provide other treatment options besides the traditional surgery, chemotherapy and radiotherapy. To know more about our services and capabilities please go through of our page and then contact us. Thank you and Mabuhay!!!